Spanish Red Biotech Pipeline

MSD

Pembrolizumanb/Enfortumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Perioperative EV + Pembrolizumab vs Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I